FDAnews Drug Daily Bulletin
Pharmaceuticals / Regulatory Affairs

DOJ Reclaimed $2.5 Billion from Healthcare-Related False Claims Cases in Fiscal 2018

Jan. 4, 2019

The Justice Department took back nearly $3 billion through judgments and settlements in fraud and false claims cases in fiscal year 2018 — with $2.5 billion of the recoveries involving the healthcare industry, including drugmakers, pharmacies and physicians.

DOJ recovered more than half a billion dollars from AmerisourceBergen and various subsidiaries. Allegedly, the wholesaler tried to raise profits by running a “sham” pharmacy that illegally repackaged an overfill of injectable supportive chemotherapy drugs under insanitary conditions.

The wholesaler settled with the department for $625 million to resolve allegations that it attempted to skirt supply chain safeguards. Of the settlement, $581.8 million went to the federal government, while $43.2 million was paid to state Medicaid programs.

View today's stories